Edition:
United States

Profile: UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

466JPY
8:47pm EST
Change (% chg)

¥2 (+0.43%)
Prev Close
¥464
Open
¥467
Day's High
¥477
Day's Low
¥462
Volume
410,300
Avg. Vol
382,087
52-wk High
¥2,755
52-wk Low
¥461

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003. As of December 31, 2012, the Company had one consolidated subsidiary.

Company Address

UMN Pharma Inc

26F, Yokohama Landmark Tower
2-2-1, Minato Mirai, Nishi-ku
YOKOHAMA-SHI   KNG   220-8126
P: +8145.2639200
F: +8145.2639205

Company Web Links